{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:15:14Z","timestamp":1714954514790},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijcard.2024.131994","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T15:29:16Z","timestamp":1712071756000},"page":"131994","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levosimendan in cardiac amyloidosis: Unveiling promising paths"],"prefix":"10.1016","volume":"406","author":[{"given":"Andrea","family":"Faggiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.131994_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2022.08.002","article-title":"Prevalence and risk factors of cardiac amyloidosis in heart failure: a systematic review and meta-analysis","volume":"31","author":"See","year":"2022","journal-title":"Heart Lung Circul."},{"issue":"16","key":"10.1016\/j.ijcard.2024.131994_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.131994_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131963","article-title":"Safety and efficacy of levosimendan in patients with cardiac amyloidosis","author":"Aimo","year":"2024","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.131994_bb0020","article-title":"Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial","volume":"9","author":"Burkhoff","year":"2021","journal-title":"JACC Hear Fail."},{"issue":"9766","key":"10.1016\/j.ijcard.2024.131994_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.131994_bb0030","first-page":"11","article-title":"Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis","author":"Ryerson","year":"2010","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131994_bb0035","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cardfail.2022.10.420","article-title":"The transition from chronic intravenous to oral levosimendan is safe and effective in patients with pulmonary hypertension with heart failure and preserved ejection fraction","volume":"29","author":"Thenappan","year":"2023","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.ijcard.2024.131994_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2021.05.022","article-title":"Changes in stressed blood volume with Levosimendan in pulmonary hypertension from heart failure with preserved ejection fraction: insights regarding mechanism of action from the HELP trial","volume":"27","author":"Brener","year":"2021","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2024.131994_bb0045","article-title":"The impact of patients with cardiac amyloidosis in HFpEF trials","volume":"9","author":"Oghina","year":"2021","journal-title":"JACC: Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131994_bb0050","article-title":"Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis","volume":"9","author":"Slivnick","year":"2022","journal-title":"Open Hear."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324005448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324005448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T03:55:09Z","timestamp":1714881309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324005448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":10,"alternative-id":["S0167527324005448"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131994","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan in cardiac amyloidosis: Unveiling promising paths","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131994"}}